Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Belluscura PLC ( (GB:BELL) ) has issued an announcement.
Belluscura PLC is assessing the impact of newly proposed US tariffs on imports, which significantly affect their Portable Oxygen Concentrators and related components manufactured in China. The company has withdrawn its market guidance for the year ending December 2025 and plans to release further information once the situation is fully evaluated.
More about Belluscura PLC
Belluscura PLC is a UK-based medical device company that specializes in developing oxygen enrichment technology for various industries and therapies.
YTD Price Performance: -86.49%
Average Trading Volume: 1,420,391
Technical Sentiment Signal: Strong Buy
Current Market Cap: £5.02M
For detailed information about BELL stock, go to TipRanks’ Stock Analysis page.